Position in IDYA
as of Mar 31, 2026
· filed May 1, 2026
Position Value
$1,666
-$62 QoQ
Shares Held
50
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GABLES CAPITAL MANAGEMENT INC. holds $10,762,759 across 8 Biotechnology names. IDYA ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
424,581 | $10,512,625 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
4,000 | $190,280 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
121 | $54,031 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
21 | $3,970 | |
| 5 | IDYA |
IDEAYA Biosciences, Inc.
This page
|
50 | $1,666 | |
| 6 | FTRE |
Fortrea Holdings Inc.
|
10 | $94 | |
| 7 | CVM |
Cel Sci Corp
|
26 | $83 | |
| 8 | LEXX |
Lexaria Bioscience Corp.
|
13 | $10 |
All Filings in IDYA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,666 | 50 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $1,728 | 50 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $1,360 | 50 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $1,051 | 50 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $819 | 50 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $1,285 | 50 | Shares | Sole | 2025-02-07 | |
| No filing history on record for this holder in this stock. | ||||||